Annals of Clinical and Translational Neurology (Feb 2022)

Risk factors and abnormal cerebrospinal fluid associate with cognitive symptoms after mild COVID‐19

  • Alexandra C. Apple,
  • Alexis Oddi,
  • Michael J. Peluso,
  • Breton M. Asken,
  • Timothy J. Henrich,
  • J. Daniel Kelly,
  • Samuel J. Pleasure,
  • Steven G. Deeks,
  • Isabel Elaine Allen,
  • Jeffrey N. Martin,
  • Lishomwa C. Ndhlovu,
  • Bruce L. Miller,
  • Melanie L. Stephens,
  • Joanna Hellmuth

DOI
https://doi.org/10.1002/acn3.51498
Journal volume & issue
Vol. 9, no. 2
pp. 221 – 226

Abstract

Read online

Abstract Cognitive post‐acute sequelae of SARS‐CoV‐2 (PASC) can occur after mild COVID‐19. Detailed clinical characterizations may inform pathogenesis. We evaluated 22 adults reporting cognitive PASC and 10 not reporting cognitive symptoms after mild SARS‐CoV‐2 infection through structured interviews, neuropsychological testing, and optional cerebrospinal fluid (CSF) evaluations (53%). Delayed onset of cognitive PASC occurred in 43% and associated with younger age. Cognitive PASC participants had a higher number of pre‐existing cognitive risk factors (2.5 vs. 0; p = 0.03) and higher proportion with abnormal CSF findings (77% vs. 0%; p = 0.01) versus controls. Cognitive risk factors and immunologic mechanisms may contribute to cognitive PASC pathogenesis.